Evidence That Niacin Inhibits Acute Vascular Inflammation and Improves Endothelial Dysfunction Independent of Changes in Plasma Lipids
- 1 May 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (5), 968-975
- https://doi.org/10.1161/atvbaha.109.201129
Abstract
Objective— To determine if niacin can confer cardiovascular benefit by inhibiting vascular inflammation and improving endothelial function independent of changes in plasma lipid and lipoprotein levels. Methods and Results— New Zealand white rabbits received normal chow or chow supplemented with 0.6% or 1.2% (wt/wt) niacin. This regimen had no effect on plasma cholesterol, triglyceride, or high-density lipoprotein levels. Acute vascular inflammation and endothelial dysfunction were induced in the animals with a periarterial carotid collar. At the 24-hour postcollar implantation, the endothelial expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and monocyte chemotactic protein-1 was markedly decreased in the niacin-supplemented animals compared with controls. Niacin also inhibited intima-media neutrophil recruitment and myeloperoxidase accumulation, enhanced endothelial-dependent vasorelaxation and cyclic guanosine monophosphate production, increased vascular reduced glutathione content, and protected against hypochlorous acid–induced endothelial dysfunction and tumor necrosis factor α–induced vascular inflammation. Conclusion— Previous human intervention studies have demonstrated that niacin inhibits coronary artery disease. This benefit is thought to be because of its ability to reduce low-density lipoprotein and plasma triglyceride levels and increase high-density lipoprotein levels. The present study showed that niacin inhibits vascular inflammation and protects against endothelial dysfunction independent of these changes in plasma lipid levels.Keywords
This publication has 36 references indexed in Scilit:
- Effects of Niacin on Cell Adhesion and Early Atherogenesis: Biochemical and Functional Findings in Endothelial CellsBasic & Clinical Pharmacology & Toxicology, 2009
- Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic OpportunitiesAntioxidants and Redox Signaling, 2008
- The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndromeInternational Journal of Clinical Practice, 2007
- Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: A subgroup analysis of the HDL-Atherosclerosis treatment studyJournal of Clinical Lipidology, 2007
- Critical role of cholesterol ester transfer protein in nicotinic acid-mediated HDL elevation in miceBiochemical and Biophysical Research Communications, 2007
- Effects of Extended-Release Niacin on Lipoprotein Particle Size, Distribution, and Inflammatory Markers in Patients With Coronary Artery DiseaseThe American Journal of Cardiology, 2006
- Production of glutathione sulfonamide and dehydroglutathione from GSH by myeloperoxidase-derived oxidants and detection using a novel LC–MS/MS methodBiochemical Journal, 2006
- Cytokines in Atherosclerosis: Pathogenic and Regulatory PathwaysPhysiological Reviews, 2006
- The NAD+Precursors, Nicotinic Acid and Nicotinamide Upregulate Glyceraldehyde-3-Phosphate Dehydrogenase and Glucose-6-Phosphate Dehydrogenase mRNA in Jurkat CellsBiochemical and Biophysical Research Communications, 1999
- Tissue Destruction by NeutrophilsThe New England Journal of Medicine, 1989